Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2007
10/11/2007WO2007113531A2 Topical drug delivery
10/11/2007WO2007113499A1 Anti-microbial compositions comprising a cationic peptide and a glycylglycine endopeptidase
10/11/2007WO2007113386A1 Peptide conjugates
10/11/2007WO2007113385A1 Diagnostic and therapeutic agents
10/11/2007WO2007113368A1 Use of hexapeptides for preparing angiotensin 1 converting enzyme medicinal products
10/11/2007WO2007113366A1 Use of compounds inducing the axonal development of neurones, therapeutic compositions containing them and applications thereof
10/11/2007WO2007113365A1 Dairy-protein-derived peptides with angiotensin 1 converting enzyme inhibitory activity
10/11/2007WO2007113361A1 Treatment of disorders caused by changes in neurone axonal development
10/11/2007WO2007113301A1 Pharmaceuticals for influencing the reaction of the human immune system
10/11/2007WO2007113205A1 Glp-1 peptide agonists
10/11/2007WO2007112757A2 A process for concentration of a polypeptide
10/11/2007WO2007112702A2 Pharmaceutical composition containing the nmb0938 protein
10/11/2007WO2007112682A1 Recombinant human parathyroid hormone-related proteins and uses thereof
10/11/2007WO2007112675A1 Vegf receptor fusion protein and use thereof
10/11/2007WO2007112566A1 Compositions and methods for treating atherosclerosis
10/11/2007WO2007112556A1 Suppression and treatment of neuropathic pain
10/11/2007WO2007112531A1 Use of protease inhibitors from bauhinia bauhinioides and/or enterolobium contortisiliquum
10/11/2007WO2007112492A1 Compounds and methods for the treatment of pain
10/11/2007WO2007096859A3 Protection of the retina against laser injury by adnf peptides such as nap and sal
10/11/2007WO2007094495A3 Novel anticancer cathepsin preparation and anticancer agent for combination therapy against cancer using the same
10/11/2007WO2007085412B1 Fgf2-binding peptides and uses thereof
10/11/2007WO2007074133A3 Compositions comprising an acylated insulin and zinc and method of making the said compositions
10/11/2007WO2007062064A3 Methods and compositions for controlling parasitic infections with bt crystal proteins
10/11/2007WO2007061434B1 A pharmaceutical formulation of glp-1 and its use for treating a metabolic syndrome
10/11/2007WO2007056227A3 Use of complement pathway inhibitors to treat ocular diseases
10/11/2007WO2007053810A9 Liposomally encapsulated reduced glutathione, including with other pharmacologic preparation, capable of administration as an oral, topical, intraoral or transmucosal, preparation, for reversal and prevention of oxidation of cholesterol and of low density lipoprotein
10/11/2007WO2007047948A3 Intranasal administration of rapid acting insulin
10/11/2007WO2007030580A3 Neuroprotectants
10/11/2007WO2007024568A3 Method of effecting a mammalian model of sepsis, severe sepsis, or septic shock
10/11/2007WO2007024368A3 Compositions and methods to control angiogenesis with cupredoxins
10/11/2007WO2007022537A3 Use of lactoferrin as a chemokine and a chemotactic modulator
10/11/2007WO2007022140A3 Methods of improving cardiac function and attenuating and/or preventing cardiac remodeling with hsp20
10/11/2007WO2007008704A3 Melanocortin receptor ligands
10/11/2007WO2006118914A3 Methods of increasing proliferation of adult mammalian cardiomyocytes through p38 map kinase inhibition
10/11/2007WO2006096392A3 Enzymes involved in astaxanthin, carotenoid and isoprenoid biosynthetic pathways, genes encoding them and methods of making and using them
10/11/2007WO2006089660A3 Method for cleaning marine collagen and the treatment thereof to form porous sponges
10/11/2007WO2006044674A3 G-protein estrogen membrane receptor
10/11/2007WO2005115394A3 Prenyl-electrostatic switch, and methods of use
10/11/2007WO2004053058A3 Junctional adhesion molecule splice variants
10/11/2007WO2004007527A3 Secreted proteins
10/11/2007US20070240236 O-glycans in the treatment of inflammatory bowel disease and cancers
10/11/2007US20070238869 Nucleotide sequences coding heavy chain of immunoglobulin specific for human tissue factor for use in prevention and treatment of thrombosis
10/11/2007US20070238862 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling
10/11/2007US20070238776 Novel Pyrroles Having Hypolipidemic Hypocholesteremic Activities, Process for Their Preparation and Pharmaceutical Compositions Containing Them and Their Use in Medicine
10/11/2007US20070238769 Bone Densifying Agent Characterized By Use Of Cathepsin K Inhibitor With Pth
10/11/2007US20070238693 Genetic modification of the lung as a portal for gene delivery
10/11/2007US20070238686 Inhibition of Chronic Myelogenous Leukemic Cell Growth By Liposomal-Antisense Oligodeoxy-Nucleotides Targeting To Grb2 or Crk1
10/11/2007US20070238684 For an improved in vitro and in vivo transformation of particular cells, for example for somatic gene therapy; diagnosis, increased infectivity for cells of low susceptibility, such as haematopoietic cells
10/11/2007US20070238683 Modified and stabilized gdf propeptides and uses thereof
10/11/2007US20070238671 Isopeptide Gap Junction Modulators
10/11/2007US20070238670 Placing an early endosome toxin selected from Diptheria toxin, Botulinum, Anthrax toxin Lethal Factor, and Anthrax toxin Edema Factor; placing in a cytosolic buffer; contacting with a cytosolic translocation factor complex, comprising beta-COP; acidification, measurement; drug screening; antiapoptosis
10/11/2007US20070238669 Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditions
10/11/2007US20070238668 Methods of using gelsolin to treat or prevent bacterial sepsis
10/11/2007US20070238667 Compositions for treatment of cancer
10/11/2007US20070238666 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence
10/11/2007US20070238665 Modified immunoglobulin fragment for use in diagnosis, prevention and treatment of cancer, inflammation and cardiovascular disease; immunotherapy; immunodiagnostics
10/11/2007US20070238664 70 Human Secreted Proteins
10/11/2007US20070238663 Use of HMGB1 to promote stem cell migration and/or proliferation
10/11/2007US20070238662 Use of ghrelin splice variant for treating cachexia and/or anorexia and/or anorexia-cachexia and/or malnutrition and/or lipodystrophy and/or muscle wasting and/or appetite-stimulation
10/11/2007US20070238661 Substance P treatment for hepatitis C
10/11/2007US20070238659 Variants of vascular endothelial cell growth factors having antagonistic properties, nucleic acids encoding the same and host cells comprising those nucleic acids
10/11/2007US20070238657 relates to nucleic acid sequences encoding a member of the fibroblast growth factor (FGF) family, and to polypeptides encoded by the nucleic acid sequence
10/11/2007US20070238656 Functionalized poly(ethylene glycol)
10/11/2007US20070238655 Methods of Using Gelsolin to Treat or Prevent Bacterial Sepsis
10/11/2007US20070238654 Compstatin and analogs thereof for eye disorders
10/11/2007US20070238653 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
10/11/2007US20070238652 Neutralization of bacterial spores
10/11/2007US20070238651 Nucleic acids and proteins of a rat ganglioside GM1-specific alpha1-2fucosyltransferase and uses thereof
10/11/2007US20070238650 Polymer-Conjugated Glycosylated Neublastin
10/11/2007US20070238649 Agents for Regulating Adiponectin Receptor Expression
10/11/2007US20070238648 Methods and compositions employing a novel stearoyl-CoA desaturase-hSCD5
10/11/2007US20070238646 Protein for use as tool in controlling plant pest; pesticides; biological pest control; moths and beetles
10/11/2007US20070238645 for attenuating progesterone's inhibition of apoptosis; for treatment of patients having a progesterone-responsive tissue disease such as endometriosis or cancer, particularly ovarian cancer
10/11/2007US20070238644 Human Chemokines CKBeta-4 and CKBeta-10/MCP-4
10/11/2007US20070238643 P62 as a risk determinant for metabolic syndrome
10/11/2007US20070238642 Production of Vascular Endothelial Cell Growth Factor and DNA Encoding Same
10/11/2007US20070238641 Pharmaceutical Combined Preparation Containing a Therapeutic Protein
10/11/2007US20070238639 Telomerase expression repressor proteins and methods of using the same
10/11/2007US20070238638 Bak promoter expression system
10/11/2007US20070238196 Methods of using an equine fc epsilon receptor alpha chain protein
10/11/2007US20070238182 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
10/11/2007US20070238178 Cancer vaccines; infections from Retrovirus, Herpesvirus, Hepadenovirus, Poxvirus, Parvovirus, Papillomavirus, or Papovavirus; reduced side effects; a hairpin RNA having a double stranded region of between 11 to 30 nucleotides; gene expression inhibition
10/11/2007US20070238151 Novel compounds
10/11/2007US20070238150 Pro4356 polypeptides
10/11/2007US20070238136 Assays and peptide substrate for determining aggrecan degrading metallo protease activity
10/11/2007US20070238135 Novel g-protein coupled receptor and dna sequences thereof
10/11/2007US20070238130 Novel Metalloproteinases
10/11/2007US20070238115 Method of Diagnosing and Treating Colon Cancer
10/11/2007US20070237826 Polymerized solid lipid nanoparticles for oral or mucosal delivery of therapeutic proteins and peptides
10/11/2007US20070237802 Inhibition of Calcification on an Endovascular Device
10/11/2007US20070237787 Methods for use of tslp and agonists and antagonists thereof
10/11/2007US20070237785 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
10/11/2007US20070237784 IdeS, an IgG-degrading enzyme of Streptococcus pyogenes
10/11/2007US20070237780 Method of preventing or reducing the risk or incidence of cancer
10/11/2007US20070237778 Using bone morphogenic protein specific immunoglobulin for treatment and prevention of osteopenia, osteomalacia, osteoporosis, osteomyeloma, osteodystrophy and paget's disease
10/11/2007US20070237777 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
10/11/2007US20070237772 Tumor association of mdl-1 and methods
10/11/2007US20070237771 Multicomponent conjugates which bind to target molecules and stimulate T cell lysis
10/11/2007US20070237770 Novel compositions and methods in cancer
10/11/2007US20070237768 Fibroblast growth factor 21 compounds fused to proteins that have the effect of extending the in vivo half-life of the polypeptides; these fusion proteins can be used to treat non-insulin dependent diabetes mellitus, obesity and metabolic syndrome
1 ... 1036 1037 1038 1039 1040 1041 1042 1043 1044 1045 1046 1047 1048 1049 1050 1051 1052 1053 1054 1055 1056 ... 3163